Abstract
Active pharmaceutical ingredient (API) purity is of major concern for pharmaceutical companies and the medical community. Reaching ultralow limits of genotoxic impurities (GTIs), imposed by strict legislation, is often time consuming and economically challenging. Therefore, there is a call for efficient unit operations able to remove GTI with minimal API losses from the organic solvent postreactional streams. This study reports for the first time a new approach to improve the performance of polybenzimidazole (PBI), a solvent-stable polymer, to efficient GTI removal. Two families of GTIs are considered, and the discovery that the use of specific thermal and pH conditioning of PBI adsorbers improves GTI removal efficiency is reported. Electrospun fibers are explored, aiming at process versatility. Similar removals of GTI, more than 97%, are achieved with virtually no API loss.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
